KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCash from Discontinued OperationsCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Amortizatization of Intangibles: 2011-2019

Historic Amortizatization of Intangibles for TherapeuticsMD (TXMD) over the last 9 years, with Dec 2019 value amounting to $197,593.

  • TherapeuticsMD's Amortizatization of Intangibles rose 56.15% to $63,155 in Q1 2020 from the same period last year, while for Mar 2020 it was $220,304, marking a year-over-year increase of 67.25%. This contributed to the annual value of $197,593 for FY2019, which is 75.68% up from last year.
  • As of FY2019, TherapeuticsMD's Amortizatization of Intangibles stood at $197,593, which was up 75.68% from $112,474 recorded in FY2018.
  • TherapeuticsMD's 5-year Amortizatization of Intangibles high stood at $197,593 for FY2019, and its period low was $32,441 during FY2015.
  • In the last 3 years, TherapeuticsMD's Amortizatization of Intangibles had a median value of $112,474 in 2018 and averaged $127,194.
  • Data for TherapeuticsMD's Amortizatization of Intangibles shows a peak YoY spiked of 75.68% (in 2019) over the last 5 years.
  • TherapeuticsMD's Amortizatization of Intangibles (Yearly) stood at $32,441 in 2015, then surged by 68.14% to $54,545 in 2016, then soared by 31.11% to $71,516 in 2017, then soared by 57.27% to $112,474 in 2018, then skyrocketed by 75.68% to $197,593 in 2019.